open access

Vol 10, No 6 (2015)
Cardiology Investigation
Published online: 2016-01-11
Get Citation

Safety of cardiological diagnostics in pregnant women

Eliza Edyta Kozyra-Pydyś, Łukasz Pydyś
DOI: 10.5603/FC.2015.0085
·
Folia Cardiologica 2015;10(6):450-456.

open access

Vol 10, No 6 (2015)
Cardiology Investigation
Published online: 2016-01-11

Abstract

Cardiovascular diseases (CVD) occur in 0.2–4% of pregnant women. Late motherhood, the coexistence of CVD risk factors and advances in the treatment of congenital heart defect are the main causes of increasing risk of CVD in women of reproductive age in developed countries. CVD is now the leading cause of death in pregnant women. The most important risk factor for morbidity and mortality is the left ventricular dysfunction. The female population requiring cardiac care before, during and after pregnancy is steadily increasing. Medical care for women with CVD must be comprehensive — it requires early diagnosis, appropriate risk stratification and the implementation of appropriate treatment by an experienced team. Adaptive changes occurring in the circulation of pregnant cause an increase of morbidity and mortality in women with CVD. In addition, certain diseases of the cardiovascular system such as hypertension may be caused by pregnancy. Cardiac diagnostics in pregnancy must be sufficiently precise and safe for mother and foetus. Most commonly used are non-invasive methods burdened with the lowest risk. Physiological changes during pregnancy may affect the interpretation of the results of additional tests. Therefore, the first examination should always be physical examination. Most diagnostic methods in cardiology are relatively safe in pregnancy. Successful care of pregnant women with CVD depend on close cooperation between many specialists and the patient herself.

Abstract

Cardiovascular diseases (CVD) occur in 0.2–4% of pregnant women. Late motherhood, the coexistence of CVD risk factors and advances in the treatment of congenital heart defect are the main causes of increasing risk of CVD in women of reproductive age in developed countries. CVD is now the leading cause of death in pregnant women. The most important risk factor for morbidity and mortality is the left ventricular dysfunction. The female population requiring cardiac care before, during and after pregnancy is steadily increasing. Medical care for women with CVD must be comprehensive — it requires early diagnosis, appropriate risk stratification and the implementation of appropriate treatment by an experienced team. Adaptive changes occurring in the circulation of pregnant cause an increase of morbidity and mortality in women with CVD. In addition, certain diseases of the cardiovascular system such as hypertension may be caused by pregnancy. Cardiac diagnostics in pregnancy must be sufficiently precise and safe for mother and foetus. Most commonly used are non-invasive methods burdened with the lowest risk. Physiological changes during pregnancy may affect the interpretation of the results of additional tests. Therefore, the first examination should always be physical examination. Most diagnostic methods in cardiology are relatively safe in pregnancy. Successful care of pregnant women with CVD depend on close cooperation between many specialists and the patient herself.

Get Citation

Keywords

cardiovascular disease, pregnancy, cardiovascular diagnosis, risk assessment

About this article
Title

Safety of cardiological diagnostics in pregnant women

Journal

Folia Cardiologica

Issue

Vol 10, No 6 (2015)

Pages

450-456

Published online

2016-01-11

DOI

10.5603/FC.2015.0085

Bibliographic record

Folia Cardiologica 2015;10(6):450-456.

Keywords

cardiovascular disease
pregnancy
cardiovascular diagnosis
risk assessment

Authors

Eliza Edyta Kozyra-Pydyś
Łukasz Pydyś

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl